05/12/22 4:01 PMNasdaq : LHDX Lucira Health Announces First Quarter 2022 Results and Business UpdateLucira Health, Inc. (Nasdaq: LHDX) (“Lucira Health,” “Lucira” or the “Company”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease tests, today reported financialRHEA-AIneutral
05/12/22 7:00 AMNasdaq : LHDX covid-19Lucira Files for Authorization of First-of-its-Kind COVID-19 & Flu At-Home Molecular TestLucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX),RHEA-AIneutral
05/09/22 8:00 AMNasdaq : LHDX covid-19Lucira Receives CE Mark for both COVID-19 & Flu and COVID-19 Molecular TestsLucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of innovative infectious disease tests, announced that both its COVID-19 & Flu and COVID-19RHEA-AIneutral
05/04/22 7:00 AMNasdaq : LHDX conferencesLucira Health to Participate in Bank of America 2022 Healthcare ConferenceLucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that the company will participate inRHEA-AIneutral
04/28/22 7:00 AMNasdaq : LHDX earningsLucira Health to Announce First Quarter 2022 Financial ResultsLucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that the company will report firstRHEA-AIneutral
04/21/22 7:00 AMNasdaq : LHDX partnershipLUCIRA HEALTH AND USA BOXING ANNOUNCE EXCLUSIVE PARTNERSHIP FOR THE 2022 SEASONLucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technologyRHEA-AIvery positive
04/11/22 6:21 PMNasdaq : LHDX Lucira Health Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that on April 6, 2022, the Board of Directors ofRHEA-AIvery positive
03/31/22 9:00 AMNasdaq : LHDX covid-19Lucira Donates Rapid Molecular At-Home COVID-19 Test Kits to Protect the Safety of Tonga Red Cross Society WorkersLucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company focused on the development and commercializationRHEA-AIneutral
03/24/22 7:00 AMNasdaq : LHDX covid-19Lucira Health's PCR-Quality At-Home COVID-19 Test Now Available Direct to Consumers in CanadaLucira Health, Inc.RHEA-AIneutral
03/10/22 4:01 PMNasdaq : LHDX Lucira Health Announces Fourth Quarter and Full Year 2021 Results and Reaffirms 2022 Financial OutlookLucira Health, Inc. (Nasdaq: LHDX) (“Lucira Health,” “Lucira” or the “Company”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today reportedRHEA-AIneutral